Dr. Han is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104
Education & Training
- Perelman School of Medicine at the University of PennsylvaniaClass of 2025
Certifications & Licensure
- NV State Medical License 1999 - 2025
- American Board of Emergency Medicine Emergency Medicine
Publications & Presentations
Journal Articles
- CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M. Bange, Nicholas A. Han, Paul Wileyto, Justin Y. Kim, Sigrid Gouma, James Robinson, Allison R. Greenplate, Madeline A. Hwee, Florence Porterfield, Olutosin Owoy..., Nature Medicine, 5/20/2021
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implicationsMathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, Kuri-Cervantes L, Pampena MB, D'Andrea K, Manne S, Chen Z, Huang YJ, Reilly JP, Weisman AR,..., Science, 7/15/2020
- Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protectionAnderson EM, Goodwin EC, Verma A, Arevalo CP, Bolton MJ, Weirick ME, Gouma S, McAllister CM, Christensen SR, Weaver J, Hicks P, Manzoni TB, Oniyide O, Ramage H, Mathew..., Cell, 4/1/2021
- Join now to see all
Abstracts/Posters
- Final results of a phase I “RadVax” trial of hypofractionated radiation combined with pembrolizumab in patients with metastatic solid tumors.John Nicholas Lukens, Rosemarie Mick, Alexander Chan Chi Huang, Nicholas Han, Michael Farwell, Tara C. Mitchell, Ravi K. Amaravadi, Lynn Mara Schuchter, Abigail T. Ber..., ASCO Journal of Clinical Oncology, 5/20/2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: